Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Derivation of Dose/Volume Constraints for the Anorectum from Clinician- and Patient-Reported Outcomes in the CHHiP Trial of Radiation Therapy Fractionation.
Wilkins A, Naismith O, Brand D, Fernandez K, Hall E, Dearnaley D, Gulliford S; CHHiP Trial Management Group. Wilkins A, et al. Among authors: brand d. Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):928-938. doi: 10.1016/j.ijrobp.2020.01.003. Epub 2020 Jan 24. Int J Radiat Oncol Biol Phys. 2020. PMID: 31987974 Free article. Clinical Trial.
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Brand DH, Tree AC, Ostler P, van der Voet H, Loblaw A, Chu W, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Henderson D, Brown S, Cruickshank C, Burnett S, Duffton A, Griffin C, Hinder V, Morrison K, Naismith O, Hall E, van As N; PACE Trial Investigators. Brand DH, et al. Lancet Oncol. 2019 Nov;20(11):1531-1543. doi: 10.1016/S1470-2045(19)30569-8. Epub 2019 Sep 17. Lancet Oncol. 2019. PMID: 31540791 Free PMC article. Clinical Trial.
Patterns of recurrence after prostate bed radiotherapy.
Brand DH, Parker JI, Dearnaley DP, Eeles R, Huddart R, Khoo V, Murray J, Suh YE, Tree AC, van As N, Parker C. Brand DH, et al. Radiother Oncol. 2019 Dec;141:174-180. doi: 10.1016/j.radonc.2019.09.007. Epub 2019 Sep 25. Radiother Oncol. 2019. PMID: 31563410
Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial.
Brand DH, Brüningk SC, Wilkins A, Fernandez K, Naismith O, Gao A, Syndikus I, Dearnaley DP, Tree AC, van As N, Hall E, Gulliford S; CHHiP Trial Management Group. Brand DH, et al. Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):596-608. doi: 10.1016/j.ijrobp.2020.12.041. Epub 2021 Jan 4. Int J Radiat Oncol Biol Phys. 2021. PMID: 33412260 Free PMC article. Clinical Trial.
The Fraction Size Sensitivity of Late Genitourinary Toxicity: Analysis of Alpha/Beta (α/β) Ratios in the CHHiP Trial.
Brand DH, Brüningk SC, Wilkins A, Naismith O, Gao A, Syndikus I, Dearnaley DP, van As N, Hall E, Gulliford S, Tree AC; CHHiP Trial Management Group. Brand DH, et al. Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):327-336. doi: 10.1016/j.ijrobp.2022.08.030. Epub 2022 Aug 17. Int J Radiat Oncol Biol Phys. 2023. PMID: 35985457 Free article. Clinical Trial.
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall E, van As N; PACE Trial Investigators. Tree AC, et al. Among authors: brand dh. Lancet Oncol. 2022 Oct;23(10):1308-1320. doi: 10.1016/S1470-2045(22)00517-4. Epub 2022 Sep 13. Lancet Oncol. 2022. PMID: 36113498 Free article. Clinical Trial.
424 results